Creative Touch Permanent Makeup and Aesthetics

Neuropeptide Y is among the most potent orexigenic peptides identified in the mammalian brain, acting through Y1 and Y5 receptors in the hypothalamic paraventricular nucleus to stimulate food intake with a characteristic preference for carbohydrate, decrease latency to eat, increase meal size, and delay satiety. It is co-expressed and co-released with AgRP from arcuate nucleus neurons, but operates over a faster timescale: where AgRP produces a slow, sustained suppression of MC4R constitutive activity lasting hours, NPY acts within minutes through Gi-coupled Y1/Y5 signalling – providing the urgent, fast-onset quality of the hunger signal that AgRP then sustains. Upstream, NPY neurons are activated by ghrelin and falling glucose and suppressed by leptin and PYY, making their firing a real-time readout of metabolic fuel availability. Beyond the arcuate, NPY neurons in the central amygdala constitute a distinct stress-responsive population whose activation drives hedonic, palatable food-seeking behaviour independently of homeostatic hunger – a circuit that emerges specifically under chronic stress conditions, including the elevated afternoon cortisol that overlaps with the four-hour post-meal glucose nadir. In the periphery, NPY functions as a sympathetic co-transmitter co-released with noradrenaline, with a pro-regenerative, anti-inflammatory profile in skin that distinguishes it sharply from the inflammatory neuropeptides substance P and CGRP.

NPY is a 36- amino acid neuropeptide belonging to the pancreatic polypeptide family – a receptor-sharing structural family that includes peptide YY (PYY) and pancreatic polypeptide (PP), all acting through the same Y1–Y5 G-protein coupled receptor system. Its wide distribution is matched by a wide functional range: in the hypothalamus it is an appetite signal; in the adrenal medulla and sympathetic nerves it is a co-transmitter with catecholamines; in the gut it modulates motility; in skin it is a pro-regenerative modulator. These are not incidental overlaps – they reflect a system that coordinates feeding behaviour with peripheral energy management through shared molecular currency.

The Central Appetite Circuit: Y1, Y5, and the Arcuate Projection

Arcuate nucleus NPY neurons project primarily to the paraventricular nucleus (PVN) of the hypothalamus, where NPY acts through Y1 and Y5 receptors on oxytocin (OXT)-positive neurons to inhibit their activity. ^[5] The mechanism is dual: NPY activates GABA-A receptors and simultaneously engages Y1- cAMP-PKA signalling in PVN OXT neurons, reducing oxytocin release. Since oxytocin in the PVN exerts an anorexigenic influence, NPY’s suppression of it acts as a disinhibition of food intake – removing a satiety brake rather than simply adding a hunger signal. NPY also projects through PVN to the nucleus tractus solitarius (NTS), where it inhibits sympathetic preganglionic neurons, reducing brown adipose tissue UCP-1 expression and lowering basal metabolic rate – coupling increased food-seeking with reduced energy expenditure simultaneously.

Both Y1 and Y5 receptors are required for the full orexigenic effect. Knockout of Y1 alone or Y5 alone produces late-onset obesity, suggesting partial redundancy; but simultaneous ablation of Y1 and Y5 in the PVN produces hypophagia and significantly reduced food intake in both spontaneous and fasting conditions. ^[8] Neither receptor alone is sufficient – their combined activation is what produces the full magnitude of NPY’s appetite-stimulating effect.

Upstream, arcuate NPY neurons are regulated by the same hormonal signals that regulate co-expressed AgRP neurons, but through their own receptor machinery:

• Ghrelin activates arcuate NPY neurons through the ghrelin receptor (GHSR), with Y1 receptor signalling required for the full ghrelin-induced foraging and food-seeking response ^[7]
• Leptin directly inhibits arcuate NPY neurons via LepRb, with leptin insufficiency or resistance producing increased hypothalamic NPY activity ^[3]
• Insulin suppresses NPY neuron activity via PI3K signalling at the arcuate level
• PYY – released from gut L cells after eating – acts at presynaptic Y2 autoreceptors on arcuate NPY neurons to inhibit NPY release, contributing to post-meal satiety through a direct gut-to-arcuate feedback loop (covered in full in the NPY Family section below)

NPY as the Fast Hunger Signal

The functional distinction between NPY and AgRP as co-expressed, co-released signals from the same neurons is temporal. NPY acts through Gi-coupled Y1/Y5 receptors to produce its orexigenic effect within minutes – a fast GPCR signalling mechanism that drives the rapid, urgent quality of hunger onset. AgRP’s inverse agonism at MC4R, by contrast, builds more slowly as it suppresses the constitutive activity of MC4R and disinhibits downstream hunger circuitry – its full effect developing over tens of minutes to hours, and persisting for considerably longer once activated.

NPY’s fast-onset profile has a specific character beyond simple appetite stimulation. It decreases latency to eat – the time from first experiencing hunger to initiating eating behaviour – increases motivation to eat, augments meal size, and delays the onset of satiety. ^[2] Critically, this orexigenic effect carries a carbohydrate preference: NPY stimulates food intake with a specific bias toward carbohydrate consumption rather than fat or protein. This selectivity is not a behavioural generalisation from secondary sources – it is an experimental finding from central NPY administration studies showing differential macronutrient intake effects.

The carbohydrate preference is mechanistically important for understanding the 4pm craving. When arcuate NPY neurons are activated by the four-hour glucose nadir – itself a consequence of the high-GI postprandial dual-curve mechanism described in [ Postprandial glucose response] – the resulting orexigenic signal is not neutral across macronutrients. NPY specifically directs intake toward carbohydrate, which is why the craving pulls characteristically toward biscuits, bread, or sweet foods rather than toward protein or fat despite those being available options. The signal is metabolically targeted: carbohydrate is the fastest route to restoring glucose availability and interrupting the CPT-1 inhibition block, and the NPY-Y1/Y5 system appears to encode that preference.

Stress, Cortisol, and the Central Amygdala NPY Axis

Beyond the arcuate, NPY-expressing neurons in the central nucleus of the amygdala (CeA) constitute a functionally distinct population with a different relationship to food intake. Where arcuate NPY neurons respond to metabolic signals (ghrelin, leptin, glucose), CeA NPY neurons respond to emotional and stress signals – and their activation drives hedonic, palatable food-seeking independently of homeostatic hunger. ^[9]

Chronic stress activates CeA NPY circuits. A 2025 translational profiling study found that high-fat diet combined with chronic stress specifically upregulates NPY expression and signalling in CeA neurons, with these neurons co-expressing orexigenic markers and showing minimal overlap with anorexigenic populations. ^[6] Chemogenetic activation of CeA NPY neurons increases consumption of both standard and palatable high-fat food in fed mice – animals that are not metabolically food-deprived – establishing the CeA NPY circuit as a driver of appetite that operates independently of energy deficit.

Glucocorticoids are the upstream link between stress and this circuit. Cortisol modulates the reward value of food via neuroendocrine mediators including NPY; chronic HPA axis activation appears to sustain CeA NPY neuron activity in a way that acute stress does not, shifting the system from transient stress-induced appetite to a more persistent hedonic feeding drive. ^[1]

The 4pm window sits at the convergence of both NPY circuits simultaneously. The circadian cortisol trough that begins in the early-to-mid afternoon represents a rapid relative glucocorticoid withdrawal – a metabolic and stress-signal change that, in individuals with chronically elevated cortisol or HPA axis dysregulation, intersects with the postprandial glucose nadir. Arcuate NPY fires because glucose has fallen and insulin is clearing; CeA NPY fires because the cortisol change registers as a stress-adjacent signal. The subjective experience – an urgent, carbohydrate-directed craving that feels both physical and emotionally compelling – is the product of both circuits firing together. See Circadian rhythm, AgRP, and POMC for the full convergence.

The NPY Family: PYY as the Gut Counterbalance

NPY belongs to a three-member peptide family sharing the Y receptor system: NPY, peptide YY (PYY), and pancreatic polypeptide (PP). Understanding NPY’s appetite function requires understanding how PYY opposes it at the gut-brain interface. ^[4]

PYY is released from enteroendocrine L cells of the distal gut following eating, proportional to caloric load. Its predominant form in circulation is PYY(3–36), which acts selectively at Y2 receptors – including the presynaptic Y2 autoreceptors on arcuate NPY neuron terminals. Activation of Y2 at these terminals inhibits NPY release from the arcuate, reducing the orexigenic drive after a meal. PYY is therefore the gut’s direct molecular brake on hypothalamic NPY activity – the post-meal satiety signal that operates by suppressing the very neurons that would otherwise sustain hunger. GLP-1 and PYY are co-released from the same L cells in response to the same nutrient stimuli; the two satiety signals act in parallel on different circuits – GLP-1 suppressing AgRP and activating POMC neurons, PYY suppressing NPY via the Y2 autoreceptor. This is why GLP-1 receptor agonist medications and meals both produce satiety: both engage these complementary gut-to-brain suppressive pathways simultaneously.

Pancreatic polypeptide (PP), released from pancreatic islet PP cells in response to eating, signals to the brainstem and hypothalamus via Y4 receptors to contribute to meal termination. PP and PYY together form the gut’s post-meal NPY-suppression system – the satiety counterpart to the appetite activation that ghrelin and falling glucose produce in the fasted state.

NPY in the Periphery and Skin

Outside the CNS, NPY functions as a co-transmitter released alongside noradrenaline from sympathetic nerve terminals – an adrenergic co-transmitter identity that makes it fundamentally different in character from sensory neuropeptides such as substance P and CGRP. Where SP and CGRP are released from sensory C-fibres in response to noxious or inflammatory stimuli and primarily drive vasodilation and immune activation, NPY is released from sympathetic terminals under conditions of sympathetic activation (stress, physical exertion, cold exposure) and primarily drives vasoconstriction and, in skin, a pro-regenerative biological programme.

In skin, NPY acts through Y1, Y2, and Y5 receptor subtypes expressed on vascular endothelial cells, keratinocytes, fibroblasts, macrophages, and hair follicle cells. Its biological profile is distinctly regenerative compared to the inflammatory neuropeptides: NPY promotes endothelial cell proliferation, migration, and angiogenesis through Y2 and Y5 receptors, contributing to the vascular phase of wound healing and tissue repair. ^[10] In the proliferative phase of wound healing, NPY modulates macrophage TNF-α secretion through β-arrestin 2 signalling, contributing to the transition from a pro-inflammatory to an anti-inflammatory macrophage phenotype – a phase transition that is central to successful wound resolution.

NPY additionally promotes hair follicle growth alongside wound repair in animal models, in direct contrast to substance P’s catagen-inducing effect. This follicular pro-growth signal represents the sympathetic nervous system’s contribution to hair cycle maintenance – the counterbalance to the stress-SP pathway that disrupts follicle cycling in neurogenic telogen effluvium. Whether this distinction has direct therapeutic implications remains to be established in clinical studies; at the mechanistic level, the opposing neuropeptide influences on the hair follicle – NPY from sympathetic terminals promoting growth, SP from sensory fibres promoting catagen – establish the autonomic-sensory neuropeptide balance as a genuine regulator of follicle cycle timing.